Moreover, OS and DFS analyses revealed that SETD5 expression was significantly associated with poor OS (p = 0.005) and DFS (p = 0.001) in patients with colon adenocarcinoma (Fig. 1F and Supplementary Tables S6 and S7). This evidence concerns the gene SETD5 and colon adenocarcinoma.